Reinhart Partners Inc. raised its holdings in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 0.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 194,302 shares of the real estate investment trust’s stock after purchasing an additional 910 shares during the period. Reinhart Partners Inc.’s holdings in Medical Properties Trust were worth $3,801,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. TD Asset Management Inc. raised its position in Medical Properties Trust by 87.2% during the 2nd quarter. TD Asset Management Inc. now owns 84,300 shares of the real estate investment trust’s stock valued at $1,470,000 after purchasing an additional 39,264 shares during the last quarter. Swiss National Bank grew its holdings in shares of Medical Properties Trust by 3.7% during the 2nd quarter. Swiss National Bank now owns 689,700 shares of the real estate investment trust’s stock worth $12,028,000 after acquiring an additional 24,600 shares during the period. Campbell Capital Management Inc. purchased a new position in shares of Medical Properties Trust during the 2nd quarter worth approximately $1,472,000. California Public Employees Retirement System grew its holdings in shares of Medical Properties Trust by 2.0% during the 2nd quarter. California Public Employees Retirement System now owns 775,397 shares of the real estate investment trust’s stock worth $13,523,000 after acquiring an additional 15,096 shares during the period. Finally, Falcon Point Capital LLC grew its holdings in shares of Medical Properties Trust by 2.1% during the 2nd quarter. Falcon Point Capital LLC now owns 179,090 shares of the real estate investment trust’s stock worth $3,123,000 after acquiring an additional 3,692 shares during the period. 71.66% of the stock is owned by institutional investors and hedge funds.
MPW has been the topic of a number of research analyst reports. ValuEngine downgraded Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Tuesday, November 5th. Stifel Nicolaus set a $21.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a report on Monday, August 12th. Zacks Investment Research upgraded Medical Properties Trust from a “hold” rating to a “buy” rating and set a $22.00 target price on the stock in a report on Wednesday, October 16th. JPMorgan Chase & Co. set a $21.00 target price on Medical Properties Trust and gave the stock a “buy” rating in a report on Wednesday, September 4th. Finally, Bank of America initiated coverage on Medical Properties Trust in a report on Monday, October 14th. They set a “neutral” rating and a $19.50 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and eight have given a buy rating to the company’s stock. The stock currently has a consensus rating of “Buy” and an average price target of $20.18.
In related news, insider Emmett E. Mclean sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $18.37, for a total value of $1,837,000.00. Following the transaction, the insider now directly owns 1,066,337 shares of the company’s stock, valued at approximately $19,588,610.69. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO R Steven Hamner sold 77,500 shares of the company’s stock in a transaction that occurred on Wednesday, September 25th. The shares were sold at an average price of $19.43, for a total value of $1,505,825.00. Following the completion of the transaction, the chief financial officer now directly owns 1,235,457 shares in the company, valued at $24,004,929.51. The disclosure for this sale can be found here. Insiders sold a total of 279,464 shares of company stock worth $5,359,673 in the last 90 days. 1.18% of the stock is currently owned by company insiders.
Shares of Medical Properties Trust stock traded up $0.53 during midday trading on Friday, hitting $19.95. The company had a trading volume of 16,826,344 shares, compared to its average volume of 4,039,835. The company has a debt-to-equity ratio of 1.02, a quick ratio of 8.00 and a current ratio of 6.27. The stock has a market capitalization of $8.56 billion, a P/E ratio of 14.56, a P/E/G ratio of 3.39 and a beta of 0.52. The company has a 50 day moving average of $19.84 and a 200 day moving average of $18.53. Medical Properties Trust, Inc. has a 52-week low of $15.25 and a 52-week high of $20.92.
Medical Properties Trust (NYSE:MPW) last posted its quarterly earnings results on Thursday, October 31st. The real estate investment trust reported $0.20 earnings per share for the quarter, missing the consensus estimate of $0.32 by ($0.12). The company had revenue of $224.70 million during the quarter, compared to analysts’ expectations of $221.40 million. Medical Properties Trust had a return on equity of 6.36% and a net margin of 41.57%. The business’s quarterly revenue was up 14.1% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.35 EPS. Equities research analysts forecast that Medical Properties Trust, Inc. will post 1.32 EPS for the current year.
About Medical Properties Trust
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Read More: How do taxes affect a CDs total return?
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.